STAT+: Pharmalittle: Investors Reject Proposals For Covid Vaccine Makers To Share Know-how; CMS Head Says Alzheimer’s Drug Decision Is Rare
CMS head Chiquita Brooks-LaSure says the agency expects to keep covering drugs that the FDA approves through its fast-track accelerated approval pathway, despite its recent decision on Biogen's Aduhelm.